Practical murine hematopathology: A comparative review and implications for research

Comparative Medicine

Volumn 65, Issue 2, 2015, Pages 96-113

  O'Connell, Karyn E ^a   Mikkola, Amy M ^b   Stepanek, Aaron M ^b,c   Vernet, Andyna ^a,b   Hall, Christopher D ^b   Sun, Chia C ^b,d   Yildirim, Eda ^b,e   Staropoli, John F ^b,f   Lee, Jeannie T ^a,b   Brown, Diane E ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMD Serono Research Institute   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f BIOGEN   (United States)

Author keywords

GEM, genetically engineered mouse; NMB, new methylene blue; nRBC, nucleated RBC; RDW, RBC distribution width; TNCC, total nucleated cell count

Indexed keywords

IRON;

ACCURACY; B LYMPHOCYTE; BASOPHIL; COMPARATIVE STUDY; DISEASE MARKER; EOSINOPHIL; ERYTHROCYTE; HEMATOLOGICAL PARAMETERS; HEMATOPOIESIS; IRON STORAGE; LEUKOCYTE COUNT; LEUKOCYTE STRUCTURE; MEDICAL RESEARCH; MONOCYTE; MOUSE MODEL; NEUTROPHIL; NONHUMAN; RETICULOCYTE; REVIEW; SPLEEN; THROMBOCYTE; ANIMAL; BLOOD; BONE MARROW; DISEASE MODEL; HEMATOLOGIC DISEASES; HEMATOLOGY; HUMAN; MOUSE; PATHOLOGY; PROCEDURES; TRANSLATIONAL RESEARCH; VETERINARY PATHOLOGY;

ANIMALS; BONE MARROW; DISEASE MODELS, ANIMAL; HEMATOLOGIC DISEASES; HEMATOLOGY; HEMATOPOIESIS; HUMANS; MICE; PATHOLOGY, VETERINARY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84929629433     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (178)

1. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S. 2003. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9:1370-1376.
2. Alemdehy MF, Van Boxtel NGJA, De Looper HWJ, Van den Berge IJ, Sanders MA, Cupedo T, Touw IP, Erkeland SJ. 2012. Dicer 1 depletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophages dendritic cell development in mice. Blood 119:4723-4730.
3. Ameri M, Schnaars HA, Sibley JR, Honor DJ. 2011. Stability of hematologic analytes in monkey, rabbit, rat, and mouse blood stored at 4 °C in EDTA using the ADVIA 120 hematology analyzer. Vet Clin Pathol 40:188-193.
4. Arroyo AE, Tabernero MD, García-Marcos MA, Orfeo A. 2005. Analytic performance of the Pentra 80 automated blood cell analyzer for the evaluation of normal and pathologic WBCs. Am J Clin Pathol 123:206-214.
5. Avasarala S, Zhang F, Liu G, Wang R, London SD, London L. 2013. Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS ONE 8:e57285.
6. Basu S. 2002. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood 100:854-861.
7. Becker M, Moritz A, Giger U. 2008. Comparative clinical study of canine and feline total blood cell count results with 7 in-clinic and 2 commercial laboratory hematology analyzers. Vet Clin Pathol 37:373-384.
8. Begley DA, Krupke DM, Neuhauser SB, Richardson JE, Bult CJ, Eppig JT, Sundberg JP. 2012. The Mouse Tumor Biology Database (MTB): A central electronic resource for locating and integrating mouse tumor pathology data. Vet Pathol 49:218-223.
9. Bienzle D. 2000. Monocytes and macrophages, p 318-325. In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
10. Biermann H, Pietz B, Dreier R, Schmid K, Sorg C, Sunderkötter C. 1999. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leukoc Biol 65:217-231.
11. Blue JT. 2000. Myelodysplastic syndromes and myelofibrosis, p 682-688. In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
12. Borggraefe I, Yuan J, Telford SR 3rd, Menon S, Hunter R, Shah S, Spielman A, Gelfand JA, Wortis HH, Vannier E. 2006. Babesia microti primarily invades mature erythrocytes in mice. Infect Immun 74:3204-3212.
13. Brayton C, Treuting PM. 2011. Phenotyping, p 7-14. In: Treuting PM, Dintzis SM, editors. Comparative anatomy and histology. Amsterdam (The Netherlands): Elsevier.
14. Brayton CF, Treuting PM, Ward JM. 2012. Pathobiology of aging mice and GEM: Background strains and experimental design. Vet Pathol 49:85-105.
15. Brockus CW. 2011. Erythrocytes, p. 3-44. In: Latimer KS, editor. Veterinary laboratory medicine: Clinical pathology. Hoboken (NJ): Wiley-Blackwell.
16. Brown DE, Libby SJ, Moreland SM, McCoy MW, Brabb T, Stepanek A, Fang FC, Detweiler CS. 2013. Salmonella enterica causes more severe inflammatory disease in C57/BL6 Nramp1G169 mice than Sv129S6 mice. Vet Pathol 50:867-876.
17. Brown DE, McCoy M, Pilonieta M, Nix R, Detweiler C. 2010. Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis. PLoS ONE 5:e9441.
18. Buchwald ZS, Kiesel JR, Yang C, Dipaolo R, Novack DV, Aurora R. 2013. Osteoclast-induced Foxp3 CD8 T cells limit bone loss in mice. Bone 56:163-173.
19. Buchwalow IB, Bèocker W. 2010. Immunohistochemistry: Basics and methods. New York (NY): Springer.
20. Burkhard MJ, Brown DE, McGrath JP, Meador VP, Mayle DA, Keaton MJ, Hoffman WP, Zimmermann JL, Abbott DL, Sun SC. 2001. Evaluation of the erythroid regenerative response in 2 different models of experimental iron deficiency anemia. Vet Clin Pathol 30:76-85.
21. Burmester H, Wolber E-M, Freitag P, Fandrey J, Jelkmann W. 2005. Thrombopoietin production in wild-type and interleukin 6 knockout mice with acute inflammation. J Interferon Cytokine Res 25:407-413.
22. Burry RW. 2010. Immunocytochemistry: A practical guide for biomedical research. New York (NY): Springer.
23. Car BD, Eng VM. 2001. Special considerations in the evaluation of the hematology and hemostasis of mutant mice. Vet Pathol 38:20-30.
24. Carter PR, Watts MN, Kosloski-Davidson M, Prasai K, Grisham MB, Harris NR. 2013. Iron status, anemia, and plasma erythropoietin levels in acute and chronic mouse models of colitis. Inflamm Bowel Dis 19:1260-1265.
25. Challen GA, Boles N, Lin KK, Goodell MA. 2009. Mouse hematopoietic stem cell identification and analysis. Cytometry Part A 75:14-24. doi: 10.1002/cyto.a.20674.
26. Chen W, Sun CC, Chen S, Meynard D, Babitt JL, Lin HY. 2013. A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum. Haematologica 98:296-304.
27. Colella R, Hollensead SC. 2012. Understanding and recognizing the Pelger-Huet anomaly. Am J Clin Pathol 137:358-366.
28. Collicutt NB, Grindem CB, Neel JA. 2012. Comparison of manual polychromatophilic cell and automated reticulocyte quantification in evaluating regenerative response in anemic dogs. Vet Clin Pathol 41:256-260. doi: 10.1111/j.1939-165X.2012.00432.x.
29. Cooper AM, Flynn JL. 1995. The protective immune response to Mycobacterium tuberculosis. Curr Opin Immunol 7:512-516.
30. Cordeiro RS, Cunha FQ, Filho JA, Flores CA, Vasconcelos HN, Martins MA. 1983. Plasmodium berghei: Physiopathological changes during infections in mice. Ann Trop Med Parasitol 77:455-465.
31. Criswell KA, Bleavins MR, Zielinski D, Zandee JC. 1998. Comparison of flow cytometric and manual bone marrow differentials. Cytometry 32:9-17.
32. Deshmane SL, Kremlev S, Amini S, Sawaya BE. 2009. Monocyte chemoattractant protein 1 (MCP1): An overview. J Interferon Cytokine Res 29:313-326.
33. Deshpande S, Bosbach B, Yozgat Y, Park CY, Moore MA, Besmer P. 2013. Kit receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion. Stem Cells 31:1683-1695.
34. Ebmeyer J, Ebmeyer U, Pak K, Sudhoff H, Broide D, Ryan AF, Wasserman S. 2010. Reconstitution of the mast cell population in W/Wv mice. Otol Neurotol 31:42-47.
35. Eckly A, Strassel C, Freund M, Cazenave JP, Lanza F, Gachet C, Leon C. 2009. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood 113:3182-3189.
36. Elmore SA. 2006. Enhanced histopathology of the bone marrow. Toxicol Pathol 34:666-686.
37. Everds N. 2007. Hematology of the laboratory mouse, p 135-163. In: Fox J, editor. The mouse in biomedical research. Waltham (MA): Academic Press.
38. Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS. 2006. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: Mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol 146:76-84.
39. Fernández I, Peña A, Del Teso N, Pérez V, Rodríguez-Cuesta J. 2010. Clinical biochemistry parameters in C57BL/6J mice after blood collection from the submandibular vein and retroorbital plexus. J Am Assoc Lab Anim Sci 49:202-206.
40. Festing MFW. 2006. Design and statistical methods in studies using animal models of development. ILAR J 47:5-14.
41. Festing MFW, Altman DG. 2002. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 43:244-258.
42. Fitts DA. 2011. Ethics and animal numbers: Informal analysis, uncertain sample sizes, inefficient replications, and type I errors. J Am Assoc Lab Anim Sci 50:445-453.
43. Folgueras AR, De Lara FM, Pendas AM, Garabaya C, Rodriguez F, Astudillo A, Bernal T, Cabanillas R, Lopez-Otin C, Velasco G. 2008. Membrane-bound serine protease matriptase 2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112:2539-2545.
44. Furuya Y, Inagaki A, Khan M, Mori K, Penninger JM, Nakamura M, Udagawa N, Aoki K, Ohya K, Uchida K, Yasuda H. 2013. Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-?B ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity. J Biol Chem 288:5562-5571.
45. Galli SJ. 2000. Mast cells and basophils. Curr Opin Hematol 7:32-39.
46. Gervais F, Attia M. 2005. Fibro-osseous proliferation in the sternums and femurs of female B6C3F1, C57BL, and CD1 mice: A comparative study. Dtsch Tierarztl Wochenschr 112:323-326.
47. Gibson JN, Jellen LC, Unger EL, Morahan G, Mehta M, Earley CJ, Allen RP, Lu L, Jones BC. 2011. Genetic analysis of iron-deficiency effects on the mouse spleen. Mamm Genome 22:556-562.
48. Golde WT, Gollobin P, Rodriguez LL. 2005. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim (NY) 34:39-43.
49. Golub R, Cumano A. 2013. Embryonic hematopoiesis. Blood Cells Mol Dis 51:226-231.
50. Gray TE, Pratt MC, Cusick PK. 1999. Determination of agreement between laboratory instruments. Contemp Top Lab Anim Sci 38:56-59.
51. Greinacher A. 2011. Platelet activation by heparin. Blood 117:4686-4687.
52. Greth A, Lampkin S, Mayura-Guru P, Rodda F, Drysdale K, Roberts-Thomson M, McMorran BJ, Foote SJ, Burgio GT. 2012. A novel ENU mutation in ankyrin 1 disrupts malaria parasite maturation in red blood cells of mice. PLoS ONE 7:e38999.
53. Grimaldi E, Scopacasa F. 2000. Evaluation of the Abbott Cell-Dyn 4000 hematology analyzer. Am J Clin Pathol 113:497-505.
54. Guan H, Zhou Z, Cao Y, Duan X, Kleinerman ES. 2009. VEGF165 promotes the osteolytic bone destruction of Ewing's sarcoma tumors by upregulating RANKL. Oncol Res 18:117-125.
55. Hao X, Fredrickson TN, Chattopadhyay SK, Han W, Qi CF, Wang Z, Ward JM, Hartley JW, Morse HC 3rd. 2010. The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. Vet Pathol 47:434-445.
56. Harvey JW. 2001. Atlas of veterinary hematology. Philadelphia (PA): Saunders.
57. Hasselbalch HC. 2014. A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera, and myelofibrosis? Leuk Res 38:263-266.
58. Hawley RG, Fong AZC, Burns BF, Hawley TS. 1992. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 176:1149-1163.
59. Hoff J. 2000. Methods of blood collection in the mouse. Lab Anim (NY) 29:47-53.
60. Hol J, Wilhelmsen L, Haraldsen G. 2010. The murine IL8 homologues KC, MIP2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies. J Leukoc Biol 87:501-508.
61. Holmberg H, Kiersgaard MK, Mikkelsen LF, Tranholm M. 2011. Impact of blood sampling technique on blood quality and animal welfare in haemophilic mice. Lab Anim 45:114-120.
62. Houwen B. 2002. Blood film preparation and staining procedures. Clin Lab Med 22:1-14.
63. Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ. 2001. Fabry disease: Preclinical studies demonstrate the effectiveness of ?-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet 68:14-25.
64. Irons RD. 1991. Blood and bone marrow, p 389-419. In: Haschek WM, Rousseaux CG, editors. Handbook of toxicologic pathology. San Diego (CA): Academic Press.
65. Jackson CW, Steward SA, Chenaille PJ, Ashmun RA, McDonald TP. 1990. An analysis of megakaryocytopoiesis in the C3H mouse: An animal model whose megakaryocytes have 32N as the modal DNA class. Blood 76:690-696.
66. Jain NC. 1993. Comparative hematologic features of some avian and mammalian species, p 54-71. In: Jain NC, editor. Essentials of veterinary hematology. Philadelphia (PA): Lea and Febiger.
67. Jay SM, Skokos EA, Zeng J, Knox K, Kyriakides TR. 2010. Macrophage fusion leading to foreign body giant cell formation persists under phagocytic stimulation by microspheres in vitro and in vivo in mouse models. J Biomed Mater Res A 93:189-199.
68. Johns JL, Christopher MM. 2012. Extramedullary hematopoiesis: A new look at the underlying stem cell niche, theories of development, and occurrence in animals. Vet Pathol 49:508-523.
69. Kang IG, Jung JH, Kim ST. 2012. Asian sand dust enhances allergeninduced Th2 allergic inflammatory changes and mucin production in BALB/c mouse lungs. Allergy Asthma Immunol Res 4:206-213. doi: 10.4168/aair.2012.4.4.206.
70. Kauppi M, Hiltona AA, Metcalfa D, Nga AP, Hylanda CD, Collingea JE, Kilea BT, Hilton DJ, Alexandera WS. 2012. Thrombocytopenia and erythrocytosis in mice with a mutation in the gene encoding the hemoglobin ? minor chain. Proc Natl Acad Sci USA 109:576-581.
71. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. 2012. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS ONE 20:256-260.
72. Kilkenny C, Parsons N, Kadyszewski E, Festing MFW, Cuthill IC, Fry D, Hutton J, Altman DG. 2009. Survey of the quality of experimental design, statistical analysis, and reporting of research using animals. PLoS ONE 4:e7824.
73. Kirabo A, Park SO, Wamsley HL, Gali M, Baskin R, Reinhard MK, Zhao ZJ, Bisht KS, Keseru GM, Cogle CR, Sayeski PP. 2012. The small-molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis. Am J Pathol 181:858-865.
74. Kirby NA, Stepanek AM, Vernet A, Schmidt SM, Schultz CL, Parry NM, Niemi SM, Fox JG, Brown DE. 2014. Urinary MCP1 and microalbumin increase prior to onset of azotemia in mice with polycystic kidney disease. Comp Med 64:99-105.
75. Knoll J. 2000. Clinical automated hematology systems, p 3-11. In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
76. Kogan SC. 2002. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100:238-245.
77. Kunder S, Calzada-Wack J, Holzlwimmer G, Muller J, Kloss C, Howat W, Schmidt J, Hofler H, Warren M, Quintanilla-Martinez L. 2007. A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: Analysis of mouse-specific and human antibodies cross-reactive with murine tissue. Toxicol Pathol 35:366-375.
78. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP. 2007. Bone marrow fibrosis: Pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 139:351-362.
79. Landoni VI, Chiarella P, Martire-Greco D, Schierloh P, van-Rooijen N, Rearte B, Palermo MS, Isturiz MA, Fernandez GC. 2012. Tolerance to lipopolysaccharide promotes an enhanced neutrophil extracellular traps formation leading to a more efficient bacterial clearance in mice. Clin Exp Immunol 168:153-163.
80. Lane SW, Sykes SM, Al-Shahrour F, Shterental S, Paktinat M, Lo Celso C, Jesneck JL, Ebert BL, Williams DA, Gilliland DG. 2010. The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. Blood 115:3489-3497.
81. Lee J, Cacalano G, Camerato T, Toy K, Moore MW, Wood W. 1995. Chemokine binding and activities mediated by the mouse IL8 receptor. J Immunol 155:2158-2164.
82. Lefkowitz JB. 2008. Heparin-induced thrombocytopenia, p 287-294. In: Kottke-Marchant K, editor. An algorithmic approach to hemostasis testing. Northfield (IL): CAP Press.
83. Léon C, Evert K, Dombrowski F, Pertuy F, Eckly A, Laeuffer P, Gachet C, Greinacher A. 2012. Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD. Blood 119:3333-3341.
84. Levin J, Ebbe S. 1994. Why are recently published platelet counts in normal mice so low. Blood 83:3829-3831.
85. Ley K, Miller YI, Hedrick CC. 2011. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 31:1506-1516.
86. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte, and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737-1746.
87. Linden M, Ward JM, Cherian S. 2011. Hematopoietic and lymphoid tissues, p 309-338. In: Trueting PM, Dintzis SM, editors. Comparative anatomy and histology: A mouse and human atlas. Amsterdam (the Netherlands): Elsevier.
88. Liu G, Bi Y, Wang R, Shen B, Zhang Y, Yang H, Wang X, Liu H, Lu Y, Han F. 2013. Kinase AKT1 negatively controls neutrophil recruitment and function in mice. J Immunol 191:2680-2690.
89. Liu J, Zhang J, Ginzburg Y, Li H, Xue F, De Franceschi L, Chasis JA, Mohandas N, An X. 2013. Quantitative analysis of murine terminal erythroid differentiation in vivo movel method to study normal and disordered erythropoeisis. Blood 121:e43-e49.
90. Lundberg P, Skoda R. 2011. Hematology testing in mice. Curr Prot Mouse Biol 1:323-346.
91. Lundorff JA, Kjelgaard-Hansen M. 2006. Method comparison in the clinical laboratory. Vet Clin Pathol 35:276-286.
92. Magez S, Caljon G. 2011. Mouse models for pathogenic African trypanosomes: Unravelling the immunology of host-parasite-vector interactions. Parasite Immunol 33:423-429.
93. Marcos R, Santos M, Santos N, Malhao F, Ferreira F, Monteiro RA, Rocha E. 2009. Use of destained cytology slides for the application of routine special stains. Vet Clin Pathol 38:94-102.
94. Mathers RA, Evans GO, Bleby J. 2013. Platelet measurements in rat, dog, and mouse blood samples using the Sysmex XT2000iV. Comp Clin Pathol 22:815-821.
95. Maue RA, Burgess RW, Wang B, Wooley CM, Seburn KL, Vanier MT, Rogers MA, Chang CC, Chang TY, Harris BT, Graber DJ, Penatti CA, Porter DM, Szwergold BS, Henderson LP, Totenhagen JW, Trouard TP, Borbon IA, Erickson RP. 2012. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Hum Mol Genet 21:730-750.
96. McCoy MW, Moreland SM, Detweiler CS. 2012. Hemophagocytic macrophages in murine typhoid fever have an antiinflammatory phenotype. Infect Immun 80:3642-3649.
97. McDonald TP, Clift RE, Cottrell MB. 1992. Large chronic doses of erythropoietin cause thrombocytopenia in mice. Blood 80:352-358.
98. Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, Morgan ES, Urban JF Jr, Dvorak AM, Finkelman FD, LeGros G, Paul WE. 2004. Basophils produce IL4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 200:507-517.
99. Monack DM, Bouley DM, Falkow S. 2004. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFN? neutralization. J Exp Med 199:231-241.
100. Moore D. 2000. Hematology of the mouse (Mus musculus), p 1219-1224. In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
101. Morohashi K-i, Tsuboi-Asai H, Matsushita S, Suda M, Nakashima M, Sasano H, Hataba Y, Li C-L, Fukata J, Irie J, Watanabe T, Nagura H, Li E. 1999. Structural and functional abnormalities in the spleen of anmFtz-F1 gene-disrupted mouse. Blood 93:1586-1594.
102. Mullally A, Poveromo L, Schneider RK, Al-Shahrour F, Lane SW, Ebert BL. 2012. Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617Fmediated polycythemia vera. Blood 120:166-172.
103. Murone M, Carpenter DA, De Sauvage FJ. 1998. Hematopoietic deficiencies in c-mpl and TPO knockout mice. Stem Cells 16:1-6.
104. Nagahisa H, Nagata Y, Ohnuki T, Osada M, Nagasawa T, Abe T, Todokoro K. 1996. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 87:1309-1316.
105. Nagarajan P, Shailendra A, Venkatesan R, Kumar MJM, Majumdar SS, Juyal RC. 2012. Sex-and strain-related differences in the peripheral blood cell values of mutant mouse strains. Comp Clin Pathol 21:1577-1585.
106. Narahara S, Matsushima H, Sakai E, Fukuma Y, Nishishita K, Okamoto K, Tsukuba T. 2012. Genetic backgrounds and redox conditions influence morphological characteristics and cell differentiation of osteoclasts in mice. Cell Tissue Res 348:81-94.
107. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. 2009. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460:259-263.
108. Nganga VK, Palmer VL, Naushad H, Kassmeier MD, Anderson DK, Perry GA, Schabla NM, Swanson PC. 2013. Accelerated progression of chronic lymphocytic leukemia in E?-TCL1 mice expressing catalytically inactive RAG1. Blood 121:3855-3866.
109. NIH Reporter. 2014. [Internet]. Research Portfolio Online Reporting Tools. [Cited 10 July 2014]. Available at: Http://projectreporter.nih. gov/reporter.cfm.
110. Oldenborg PA. 2002. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 99:3500-3504.
111. Onah DN, Wakelin D. 2000. Murine model study of the practical implication of trypanosome-induced immunosuppression in vaccinebased disease control programmes. Vet Immunol Immunopathol 74:271-284.
112. Ooi YY, Rahmat Z, Jose S, Ramasamy R, Vidyadaran S. 2013. Immunophenotype and differentiation capacity of bone marrowderived mesenchymal stem cells from CBA/Ca, ICR, and Balb/c mice. World J Stem Cells 5:34-42.
113. Papasouliotis K, Cue S, Crawford E, Pinches M, Dumont M, Burley K. 2006. Comparison of white blood cell differential percentages determined by the inhouse LaserCyte hematology analyzer and a manual method. Vet Clin Pathol 35:295-302.
114. Percy DH, Barthold SW. 2007. Mouse, p. 3-124. In: Percy DH, Barthold SW, editors. Pathology of laboratory rodents and rabbits. Ames (IA): Blackwell Publishing.
115. Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock P, Macleod M, Mignini LE, Jayaram P, Khan KS. 2007. Comparison of treatment effects between animal experiments and clinical trials: Systematic review. Br Med J 334:197.
116. Peters LL, Cheever EM, Ellis HR, Magnani PA, Svenson KL, Von Smith R, Bogue MA. 2002. Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics 11:185-193.
117. Phan VT, Wu X, Cheng JH, Sheng RX, Chung AS, Zhuang G, Tran C, Song Q, Kowanetz M, Sambrone A, Tan M, Meng YG, Jackson EL, Peale FV, Junttila MR, Ferrara N. 2013. Oncogenic RAS pathway activation promotes resistance to antiVEGF therapy through G-CSF-induced neutrophil recruitment. Proc Natl Acad Sci USA 110:6079-6084.
118. Pipitone S, Pavesi F, Testa B, Bardi M, Perri GB, Gennari D, Lippi G. 2012. Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens Advia 2120. Clin Chem Lab Med 50:1857-1859.
119. Provencher Bolliger A, Everds NE, Zimmerman KL, Moore DM, Smith SA, Barnhart KF. 2010. Hematology of laboratory animals, p 852-887. In: Weiss D, Wardrop J, Schalm OW, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
120. PubMed. 2014. [Internet]. PubMed-Official Site. [Cited 10 July 2014]. Available at: Http://www.ncbi.nlm.nih.gov/pubmed
121. Putz G, Rosner A, Nuesslein I, Schmitz N, Buchholz F. 2006. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene 25:929-939.
122. Qian S, Fu F, Li W, Chen Q, Sauvage FJ. 1998. Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood 92:2189-2191.
123. Raabe BM, Artwohl JE, Purcell JE, Lovaglio J, Fortman JD. 2011. Effects of weekly blood collection in C57BL/6 mice. J Am Assoc Lab Anim Sci 50:680-685.
124. Raben N, Wong A, Ralston E, Myerowitz R. 2012. Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgotten. Am J Med Genet C Semin Med Genet 160C:13-21.
125. Ramsey H, Zhang Q, Brown DE, Steensma DP, Lin CP, Wu MX. 2014. Stress-induced hematopoietic failure in the absence of immediate early response gene X1. Haematologica 99:282-291.
126. Raskin RE. 2010. Cytochemical staining, p 1141-1156. In: Weiss DJ, Wardrop KJ, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
127. Reagan WJ, Irizarry-Rovira A, Poitout-Belissent F, Bolliger AP, Ramaiah SK, Travlos G, Walker D, Bounous D, Walter G. 2011. Best practices for evaluation of bone marrow in nonclinical toxicity studies. Vet Clin Pathol 40:119-134.
128. Rehg JE, Bush D, Ward JM. 2012. The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissues and interpretation of proliferative and inflammatory lesions of mice and rats. Toxicol Pathol 40:345-374.
129. Rittinghausen S, Kohler M, Kamino K, Dasenbrock C, Mohr U. 1997. Spontaneous myelofibrosis in castrated and ovariectomized NMRI mice. Exp Toxicol Pathol 49:351-353.
130. Russell ES, Bernstein SE. 1966. Blood and blood formation, p 351-372. In: Green EL, editor. Biology of the laboratory mouse. New York (NY): McGraw Hill.
131. Russell WMS, Burch RL. 1959. The principles of humane experimental technique. London (United Kingdom): Methuen.
132. Samuels A, Perry MJ, Tobias JH. 1999. High-dose estrogen induces De novo medullary bone formation in female mice. J Bone Miner Res 14:178-186.
133. Schlegel R, MacGregor JT. 1983. A rapid screen for cumulative chromosomal damage in mice, accumulation of circulating micronucleated erythrocytes. Mutat Res 113:481-487.
134. Schmitt A, Guichard J, Masse J-M, Debili N, Cramer EM. 2001. Of mice and men: Comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol 29:1295-1302.
135. Schwab CL, Fan R, Zheng Q, Myers LP, Hebert P, Pruett SB. 2005. Modeling and predicting stress-induced immunosuppression in mice using blood parameters. Toxicol Sci 83:101-113.
136. Seder RA, Paul WE, Dvorak AM, Sharkis SJ, Kagey-Sobotka A, Niv Y, Finkelman FD, Barbier SA, Galli SJ, Plaut M. 1991. Mouse splenic and bone marrow cell populations that express high-affinity FcE receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci USA 88:2835-2839.
137. Sellers RS, Clifford CB, Treuting PM, Brayton C. 2012. Immunological variation between inbred laboratory mouse strains: Points to consider in phenotyping genetically immunomodified mice. Vet Pathol 49:32-43.
138. Senchenkova EY, Komoto S, Russell J, Almeida-Paula LD, Yan LS, Zhang S, Granger DN. 2013. Interleukin 6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis. Am J Pathol 183:173-181.
139. Senyuk V, Rinaldi CR, Li D, Cattaneo F, Stojanovic A, Pane F, Du X, Mahmud N, Dickstein J, Nucifora G. 2009. Consistent upregulation of Stat3 independently of Jak2 mutations in a new murine model of essential thrombocythemia. Cancer Res 69:262-271.
140. Shetty VT. 2001. Pseudo Pelger-Huet anomaly in myelodysplastic syndrome: Hyposegmented or apoptotic neutrophil? Blood 98:1273-1275.
141. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762-774.
142. Shirasaki Y, Ito Y, Kikuchi M, Imamura Y, Hayashi T. 2012. Validation studies on blood collection from the jugular vein of conscious mice. J Am Assoc Lab Anim Sci 51:345-351.
143. Shultz LD, Lyons BL, Burzenski LM, Gott B, Samuels R, Schweitzer PA, Dreger C, Herrmann H, Kalscheuer V, Olins AL, Olins DE, Sperling K, Hoffmann K. 2003. Mutations at the mouse ichthyosis locus are within the lamin B receptor gene-a single gene model for human Pelger-Huët anomaly. Hum Mol Genet 12:61-69.
144. Smith GS. 2000. Neutrophils, p. 281-296. In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
145. Snider CL, Dick EJ Jr, McGlasson DL, Robbins MC, Sholund RL, Bommineni YR, Hubbard GB. 2009. Evaluation of 4 hematology and a chemistry portable benchtop analyzers using nonhuman primate blood. J Med Primatol 38:390-396.
146. Socolovsky M, Nam H-s, Fleming MD, Haase VH, Brugnara C, Lodish HF. 2001. Ineffective erythropoiesis in Stat5a?/?5b?/? mice due to decreased survival of early erythroblasts. Blood 98:3261-3273.
147. Staropoli JF, Haliw L, Biswas S, Garrett L, Hölter SM, Becker L, Skosyrski S, Da Silva-Buttkus P, Calzada-Wack J, Neff F, Rathkolb B, Rozman J, Schrewe A, Adler T, Puk O, Sun M, Favor J, Racz I, Bekeredjian R, Busch DH, Graw J, Klingenspor M, Klopstock T, Wolf E, Wurst W, Zimmer A, Lopez E, Harati H, Hill E, Krause DS, Guide J, Dragileva E, Gale E, Wheeler V, Boustany RM, Brown DE, Breton S, Ruether K, Gailus-Durner V, Fuchs H, De Angelis MH, Cotman S. 2012. Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS ONE 7:e38310.
148. Stockham SL. 2008. Leukocytes, p 53-106. In: Stockham SL, Scott MA, editors. Fundamentals of veterinary clinical pathology. Ames (IA): Blackwell Publishing.
149. Stoffel R, Wiestner A, Skoda R. 1996. Thrombopoietin in thrombocytopenic mice-evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87:567-573.
150. Strassel C, Eckly A, Leon C, Petitjean C, Freund M, Cazenave JP, Gachet C, Lanza F. 2009. Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome. Haematologica 94:800-810.
151. Sudo K, Ema H, Morita Y, Nakauchi H. 2000. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 192:1273-1280.
152. Sun CC, Vaja V, Babitt JL, Lin HY. 2012. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol 87:392-400.
153. Suttie AW. 2006. Histopathology of the spleen. Toxicol Pathol 34:466-503.
154. Takaku T, Malide D, Chen J, Calado RT, Kajigaya S, Young NS. 2010. Hematopoiesis in 3 dimensions: Human and murine bone marrow architecture visualized by confocal microscopy. Blood 116:e41-e55.
155. Tomlinson L, Boone LI, Ramaiah L, Penraat KA, von Beust BR, Ameri M, Poitout-Belissent FM, Weingand K, Workman HC, Aulbach AD, Meyer DJ, Brown DE, Macneill AL, Bolliger AP, Bounous DI. 2013. Best practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and biotechnology industries. Vet Clin Pathol 42:252-269. .
156. Travlos GS. 2006. Normal structure, function, and histology of the bone marrow. Toxicol Pathol 34:548-565.
157. Treuting PM, Clifford CB, Sellers RS, Brayton CF. 2012. Of mice and microflora: Considerations for genetically engineered mice. Vet Pathol 49:44-63.
158. Tvedten H. 1993. Advanced hematology analyzers: Interpretation of results. Vet Clin Pathol 22:72-80.
159. Tvedten H. 2009. Atypical mitoses. Vet Clin Pathol 38:418-420.
160. Van Furth R. 1989. Origin and turnover of monocytes and macrophages. Curr Top Pathol 79:125-150.
161. Vap LM, Harr KE, Arnold JE, Freeman KP, Getzy K, Lester S, Friedrichs KR. 2012. ASVCP quality assurance guidelines: Control of preanalytical and analytical factors for hematology for mammalian and nonmammalian species, hemostasis, and crossmatching in veterinary laboratories. Vet Clin Pathol 41:8-17.
162. Walton RM. 2012. Subject-based reference values: Biological variation, individuality, and reference change values. Vet Clin Pathol 41:175-181.
163. Wancket LM, Devor-Henneman D, Ward JM. 2008. Fibroosseous (FOL) and degenerative joint lesions in female outbred NIH Black Swiss mice. Toxicol Pathol 36:362-365.
164. Ward JM, Rehg JE, Morse HC 3rd. 2012. Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias. Toxicol Pathol 40:425-434.
165. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, Shimizu N, Honda M, Yamamoto N. 2007. Hematopoietic stem cell-engrafted NOD/SCID/IL2R?-null mice develop human lymphoid systems and induce long-lasting HIV1 infection with specific humoral immune responses. Blood 109:212-218.
166. Webb JL, Latimer KS. 2011. Leukocytes, p 45-82. In: Latimer KS, editor. Veterinary laboratory medicine: Clinical pathology. Hoboken (NJ): Wiley-Blackwell.
167. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, Lira SA, Bravo R. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF?B-Rel family. Cell 80:331-340.
168. Weiser G. 2012. Laboratory technology for veterinary medicine, p 3-33. In: Thrall MA, Weiser G, Allison RW, editors. Veterinary hematology and clinical chemistry. Hoboken (NJ): John Wiley and Sons.
169. Weiser G. 2012. Neutrophil production, trafficking, and kinetics, p. 123-126. In: Thrall MA, Weiser G, Allison RW, editors. Veterinary hematology and clinical chemistry. Hoboken (NJ): John Wiley and Sons.
170. Weiss DJ, Wilkerson MJ. 2010. Flow cytometry, p 1047-1081. In: Weiss DJ, Wardrop KJ, editors. Schalm's veterinary hematology. Hoboken (NJ): Wiley-Blackwell.
171. Wickstrom SL, Oberg L, Karre K, Johansson MH. 2014. A genetic defect in mice that impairs missing self recognition despite evidence for normal maturation and MHC class I-dependent education of NK cells. J Immunol 192:1577-1586.
172. Yaccoby S, Barlogie B, Epstein J. 1998. Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations. Blood 92:2908-2913.
173. Yamada Y, Cancelas JA, Rothenberg ME. 2009. Murine model of hypereosinophilic syndromes/chronic eosinophilic leukemia. Int Arch Allergy Immunol 149 Suppl 1:102-107.
174. Yildirim E, Kirby J, Brown D, Mercier F, Sadreyev R, Scadden D, Lee J. 2013. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 152:727-742.
175. Yin L, Unger EL, Jellen LC, Earley CJ, Allen RP, Tomaszewicz A, Fleet JC, Jones BC. 2012. Systems genetic analysis of multivariate response to iron deficiency in mice. Am J Physiol Regul Integr Comp Physiol 302:R1282-R1296.
176. Zeiss CJ, Ward JM, Allore HG. 2012. Designing phenotyping studies for genetically engineered mice. Vet Pathol 49:24-31.
177. Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Homig-Holzel C, Wang Z, Derudder E, Li S, Chakraborty T, Cotter SE, Koyama S, Currie T, Freeman GJ, Kutok JL, Rodig SJ, Dranoff G, Rajewsky K. 2012. Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell 148:739-751.
178. Zhu M, Lovell KL, Patterson JS, Saunders TL, Hughes ED, Friderici KH. 2005. ?-mannosidosis mice: A model for the human lysosomal storage disease. Hum Mol Genet 15:493-500.